NeurogesX, Inc. (NASDAQ:NGSX)

CAPS Rating: 1 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

Recs

0
Player Avatar siri22 (< 20) Submitted: 1/31/2012 12:59:38 AM : Outperform Start Price: $1.04 NGSX Score: -66.31

Junk

Report this Post Reply

Featured Broker Partners


Advertisement